Alpha and beta adrenergic-induced renin release in man

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Pharmacology

Background:

• Adrenergic agonists influence hemodynamic variables and renin release.
• Understanding the differential effects of alpha and beta adrenergic stimulation on renin is crucial for cardiovascular research.

Purpose of the Study:

• To investigate the effects of alpha and beta adrenergic agonists on hemodynamic variables and plasma renin activity in humans.
• To determine if propranolol, a beta-blocker, influences agonist-induced renin release and cardiovascular changes.

Main Methods:

• Five healthy men received infusions of saline, methoxamine (alpha-agonist), and isoproterenol (beta-agonist) in a randomized order.
• Plasma renin activity was measured using radioimmunoassay.
• The effects of propranolol were assessed on cardiovascular parameters and renin activity.

Main Results:

• Both methoxamine and isoproterenol dose-dependently increased plasma renin activity, with similar magnitudes.
• Cardiovascular changes induced by the agonists were in opposite directions as predicted.
• Propranolol decreased systolic pressure and heart rate, and significantly reduced plasma renin activity.
• Propranolol blocked the renin-releasing effects of both agonists but only the cardiovascular effects of isoproterenol.

Conclusions:

• Alpha and beta adrenergic agonists stimulate renin release equally in humans.
• A step in renin release is sensitive to propranolol, potentially independent of its beta-receptor blocking activity.
• These findings provide insights into the complex regulation of the renin-angiotensin system by adrenergic pathways.